Atlas Trials

A Phase II/III Study of Cysteamine (Mercaptoethylamine) and Zidovudine for the Treatment of HIV Disease

Clinical trial NCT00002110 · COMPLETED

Trial details

NCT number
NCT00002110
Sponsor
Mylan Laboratories
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
HIV Infections
Enrollment
300

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.